Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland Entertainment Insider.
EL PASO, TEXAS REALTOR® VINCE SIERRA EARNS HIS MILITARY RELOCATION PROFESSIONAL (MRP) CERTIFICATION
EIN Presswire
·
September 2, 2024
EL PASO, TEXAS, USA, September 2, 2024 /EINPresswire.com/ -- Vince Sierra is a refined, debonair, courteous, and trustworthy Real Estate Agent and Broker at the prestigious Sierra Realty TX in El Paso, Texas. He is also a highly decorated...
Oculis to Present at Upcoming September Investor Conferences
GlobeNewswire, Inc.
·
August 29, 2024
ZUG, Switzerland, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ management will be attending...
The Panharmonion Chronicles: an award-winning London oddity
EIN Presswire
·
February 22, 2024
"The Panharmonion Chronicles: A genre-bending, super-powered time travel tale packed with unique perspectives and fantastical concepts.” SCIFI NOW LONDON, UK, February 22, 2024 /EINPresswire.com/ -- Henry Chebaane’s debut graphic novel and its...
Alvotech Enters into Exclusive Licensing Agreement with Kashiv BioSciences for Development and Commercialization of a Proposed Biosimilar to Xolair® (omalizumab)
GlobeNewswire, Inc.
·
October 3, 2023
REYKJAVIK, Iceland and PISCATAWAY, N.J., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Kashiv Biosciences LLC...
European Commission Decision to approve the pediatric use of antifungal Cresemba® (isavuconazole) and extension of market exclusivity triggers CHF 10 million milestone payment to Basilea
GlobeNewswire, Inc.
·
August 27, 2024
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, August 27, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and...
Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older
GlobeNewswire, Inc.
·
January 31, 2025
First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old. The virus-like particle (VLP) single-dose chikungunya vaccine is expected to launch in key European markets in the first half of 2025, pending final marketing...
Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million
GlobeNewswire, Inc.
·
January 30, 2025
Saint Herblain (France), January 30, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32.8 million contract with the United States (U.S.) Department of Defense (DoD) for the...
BMG & Too Lost Extend Publishing Partnership
EIN Presswire
·
February 28, 2024
LOS ANGELES, CA, USA, February 28, 2024 /EINPresswire.com/ -- Music and technology company Too Lost, has announced the extension of their publishing administration partnership with BMG. Since first partnering together in 2021, the highly...
Women's Award for Princess Antonia, Prince Waldemar and their son Prince Mario-Max Schaumburg-Lippe - Royals Awarded USA
EIN Presswire
·
March 8, 2024
The Women's International Center Awarded German Royals Prince Waldemar, Dr. Princess Antonia and Dr. Prince Mario-Max Schaumburg-Lippe, the Hollywood TV-Host! SAN DIEGO, CALIFORNIA, USA, March 8, 2024 /EINPresswire.com/ -- Prince Mario-Max zu...
Greenland During Trump 2.0: Is America Poised for an Historic Arctic Territorial Expansion?
The Arctic Institute
·
January 21, 2025
Back to Publications The aircraft that carried then U.S Secretary of State John Kerry to Greenland in 2016, sitting on the runway at Kangerlussuaq International Airport in Kangerlussuaq, Greenland. Photo: U.S. Department of State It was just over...
STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe
GlobeNewswire, Inc.
·
July 22, 2024
Launch of European-made Uzpruvo in Europe comes immediately upon expiry of exclusivity rights for the molecule used to treat certain conditions in gastroenterology1, dermatology and rheumatology Creates competition at earliest opportunity,...
World Handball Championship in Zagreb brings attention to the role of the Slovenian minority in Croatia
Government of Slovenia
·
January 21, 2025
SLOVENIA, January 21 - The Deputy Prime Minister of the Republic of Slovenia and Minister for Slovenians Abroad, Matej Arčon, and the State Secretary at the Government Office for Slovenians Abroad, Vesna Humar, are on a two-day visit to Zagreb....
Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer
GlobeNewswire, Inc.
·
August 15, 2024
Dr. Klier brings significant experience in ophthalmology and drug development with a proven track record in U.S. FDA approvals, which will be instrumental as the company advances its late-stage pipeline Appointment further expands Oculis’...
KAATSU to Showcase Its Groundbreaking Performance and Recovery Technology at the 2024 Paris Olympic Games
EIN Presswire
·
July 26, 2024
At the request of the WOA, KAATSU will demonstrate its cutting-edge tech for athletes at OLY House in Paris during the 2024 Olympics from July 26 to August 11. PARIS, FRANCE, July 26, 2024 /EINPresswire.com/ -- KAATSU Global has been invited by...
Pharmacy Management System Market Expected to Grow Consistently at 10.67% CAGR to 183.43 Billion USD
EIN Presswire
·
January 21, 2025
Pharmacy Management System Market Insights: Growing need for efficient inventory management and patient engagement drives adoption. US, NY, UNITED STATES, January 21, 2025 /EINPresswire.com/ -- Market Research Future Latest Industry Insights on...
Alvotech to Report Financial Results for the First Half of 2023 on August 30, 2023, and Host Business Update Conference Call on August 31, 2023, at 8:00 am ET
GlobeNewswire, Inc.
·
August 22, 2023
REYKJAVIK, Iceland, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial...
218,000 flight disruptions in Europe last year may lead to over 6 billion euros in compensation
EIN Presswire
·
January 13, 2025
Only about a third of affected passengers contact airlines or compensation management companies. VILNIUS, LITHUANIA, January 13, 2025 /EINPresswire.com/ -- According to data from compensation management company Skycop.com, nearly 218,000...
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
GlobeNewswire, Inc.
·
January 29, 2024
The study, which assessed the pharmacokinetics, safety, and tolerability of AVT03 compared to Prolia® in healthy adult subjects, met its primary endpoints Prolia® and Xgeva® (denosumab) are indicated for the treatment of bone disease REYKJAVIK,...
Nordic Building Automation and Control Market to See Surge in Demand for Smart Solutions by 2027
EIN Presswire
·
January 14, 2025
Nordic Building Automation and Control Market Expected to reach $3.18 Billion by 2027 WILMINGTON, DE, UNITED STATES, January 14, 2025 /EINPresswire.com/ -- Allied Market Research, titled, "Nordic Building Automation and Control Market by Product...
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 43rd Annual J.P. Morgan Healthcare Conference 2025
GlobeNewswire, Inc.
·
January 13, 2025
CAMPBELL, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs,...